Long-term, flexible therapy strategies are needed for chronic diseases like cardiovascular ailments, diabetes, and chronic kidney disease and they have to deal with patient heterogeneity, changing physiological states and privacy constraints. This research suggests a framework for privacy-preserving and personalized artificial intelligence that combines Federated Learning (FL), a Res-HyperTransformerNet deep prediction model, Personalized Multi-Agent Reinforcement Learning (PMARL) and Explainable Artificial Intelligence (XAI) for adaptive chronic disease management. The framework is structured with two main aims: (i) to create an accurate and privacy-aware predictive model for chronic disease risk using diverse data sources, and (ii) to permit adaptive, individual therapy optimization through multi-agent reinforcement learning. Federated learning is utilized to conduct the training of Res-HyperTransformerNet over distributed Internet of Medical Things (IoMT) nodes without the requirement of transferring raw patient data. The embeddings that are created from patient data are then passed on to a PMARL module, where several agents optimize therapy dimensions like medications, diet, physical activity, and mental health interventions independently. To make the clinical support more understandable, the SHAP-based explainability method is used for both predictive and decision-making parts. The framework is tested using two public datasets—the CDC Chronic Disease dataset and the UCI Chronic Kidney Disease Risk Factor dataset. The performance is measured by employing classification metrics (accuracy, precision, recall, F1-score, MCC) as well as reinforcement learning metrics (reward score, convergence steps, episode return) and federated system metrics (communication overhead, convergence rounds, and training time). The experiments indicate that the proposed framework demonstrated improved performance in terms of predictive accuracy and policy convergence speed compared to the baseline deep learning and reinforcement learning models, and at the same time it is more cost-effective when it comes to communication in a federated setting. This means that the proposed method suggests the potential of being a reproducible and open AI framework for adaptive chronic disease therapy management. The combination of ResNet and Transformer blocks, i.e., Federated Res-HyperTransformerNet, achieved strong performance in both datasets, namely CDC Chronic Disease (Dataset 1) and UCI CKD Risk Factor (Dataset 2). The obtained accuracy for Dataset 1 was 98.61% and for Dataset 2, it was 97.75%, under the conducted experimental settings.
Temporal Lobe Epilepsy (TLE), a very common type of focal epilepsy, requires early and precise identification to enable prompt treatment and enhance patient outcomes. Traditional methods of detection, most notably manual MRI interpretation, tend to be time-consuming, subjective, and dependent on expert specialists, hindering their scalability and reliability. Due to the limitations of conventional and current automated systems—e.g., poor feature extraction, poor segmentation, and low accuracy in classification—this work presents NeuroTLEDNet, a new end-to-end artificial intelligence model for early TLE detection from medical images. The new methodology integrates multiple series of innovations across every processing phase. In preprocessing, skull stripping, Gaussian blurring, and color normalization are used to improve image uniformity and suppress irrelevant structures. In segmentation, the improved TLE-SegNet + is suggested—based on Mask R-CNN and supplemented with DarkNet-53, DenseNet, HetConv layers, and Attention Feature Pyramid Networks (FPN)—to facilitate highly accurate delineation of epileptogenic areas. For further describing the segmented areas, a rich feature space encompassing color histograms, Local Binary Patterns (LBP), and geometric features (eccentricity, area, perimeter) is developed. To resolve inefficiencies in feature selection, this paper presents the Squirrel Reptilian Optimization (SRO) algorithm, a new hybrid metaheuristic that incorporates both the Squirrel Search Algorithm (SSA) and the Reptile Search Algorithm (RSA). The hybrid enhances discriminative feature selection by handling exploration and exploitation dynamics better compared to individual methods. For categorization, NeuroTLEDNet utilizes an in-depth hybrid ensemble of 3D Convolutional Neural Networks (3D-CNN), Recurrent Neural Networks (RNN), Radial Basis Function Networks (RBFN), and SqueezeNet, facilitating powerful modeling of spatial-temporal relationships in brain MRI scans. Tested on an 80/30 split MRI dataset, the designed model attains a remarkable accuracy of 98.6%, outperforming current methods like CNN-LSTM (94.2%), Mask R-CNN (92.7%), and ResNet-based architectures (93.1%). Indeed, NeuroTLEDNet provides an end-to-end solution for the shortcomings of existing TLE detection methods by utilizing advanced preprocessing, segmentation, feature optimization, and hybrid classification, with state-of-the-art performance in terms of both accuracy and explainability. The suggested model is a promising candidate for clinical application, and it has the potential to assist neurologists in faster and more accurate TLE diagnosis.
Chronic obstructive pulmonary disease (COPD) is a progressive respiratory condition, contributing significantly to global morbidity and mortality. Traditional diagnostic tools are effective in diagnosing COPD. However, these tools demand specialized equipment and expertise. Advances in artificial intelligence (AI) provide a platform for enhancing COPD diagnosis by leveraging diverse data modalities. The existing reviews primarily focus on single modalities and lack information on interpretability and explainability. Thus, this review intends to synthesize the AI-powered frameworks for COPD identification, focusing on data modalities, methodological innovation, evaluation strategies, and reporting limitations and potential biases. By adhering to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, a systematic search was conducted across multiple repositories. From an initial pool of 1978 records, 22 studies were included in this review. The included studies demonstrated exceptional performance in specific settings. Most studies were retrospective and limited in diversity, lacking generalizability and external or prospective validation. This review presents a roadmap for advancing AI-assisted COPD detection. By highlighting the strengths and limitations of existing studies, it supports the development of future research. Future studies can utilize the findings to build models using prospective, multicenter, and multi-ethnic validations, ensuring generalizability and fairness.
Breast cancer remains the most prevalent cancer among women, where accurate and interpretable analysis of pathology images is vital for early diagnosis and personalized treatment planning. However, conventional single-network models fall short in balancing both performance and explainability—Convolutional Neural Networks (CNNs) lack the capacity to capture global contextual information, while Transformers are limited in modeling fine-grained local details. To overcome these challenges and contribute to the advancement of Explainable AI (XAI) in precision cancer diagnosis, this paper proposes MVT-OFML (Multi-View Transformer Online Fusion Mutual Learning), a novel and interpretable classification framework for breast cancer pathology images. MVT-OFML combines ResNet-50 for extracting detailed local features and a multi-view Transformer encoding module for capturing comprehensive global context across multiple perspectives. A key innovation is the Online Fusion Mutual Learning (OFML) mechanism, which enables bidirectional knowledge sharing between the CNN and Transformer branches by aligning both intermediate feature representations and prediction logits. This mutual learning framework enhances performance while also producing interpretable attention maps and feature-level visualizations that reveal the decision-making process of the model—promoting transparency, trust, and clinical usability. Extensive experiments on the BreakHis and BACH datasets demonstrate that MVT-OFML significantly outperforms the strongest baseline models, achieving accuracy improvements of 0.90% and 2.26%, and F 1 -score gains of 4.75% and 3.21%, respectively. By integrating complementary modeling paradigms with explainable learning strategies, MVT-OFML offers a promising AI solution for precise and interpretable breast cancer diagnosis and prognosis, supporting informed decision-making in clinical settings.
breast cancerhistopathological image classificationexplainable AICNN-Transformer hybrid
Hematological biomarkers have emerged as powerful tools in diagnosing Acute Heart Failure (AHF). This study introduces a novel diagnostic framework that integrates Explainable Artificial Intelligence (XAI) with Morris Sensitivity Analysis (MSA) to enhance both the interpretability and performance of machine learning models in AHF detection. A dataset consisting of 425 AHF patients and 430 controls was analyzed using eight machine learning models, including XGBoost, Histogram-based Gradient Boosting (histGB), Explainable Boosting Machine (EBM), and Random Forest. Model performance was evaluated through metrics such as AUC, accuracy, precision, recall, and Brier score. Hyperparameters were optimized via Bayesian optimization. Feature importance was assessed using MSA to identify variables with the highest predictive influence. The histGB model achieved the highest performance with an AUC of 87.93%. Both MSA and EBM consistently identified PDW, RDW-CV, NEU, NEU/LY ratio, age, and WBC as top predictive features across multiple models. These hematological markers demonstrated strong potential for early diagnosis and risk stratification in AHF patients. This study presents a clinically relevant, interpretable, and cost-effective diagnostic strategy that combines XAI with MSA for AHF prediction. The framework enhances clinical trust and provides a pathway toward personalized treatment by identifying accessible hematological biomarkers. The integration of explainability into AI models improves their transparency and applicability in real-world clinical settings.